Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Laura Huppert, MD
Conference Coverage
Routine Screening for Brain Metastases Among Patients With HER2-Positive Breast Cancer
05/14/2024
Laura Huppert, MD
At Great Debates and Updates in Women’s Oncology, Laura Huppert, MD, argued that routine screening for brain metastases is unnecessary for patients with either early or metastatic HER2-positive breast cancer.
At Great Debates and Updates in Women’s Oncology, Laura Huppert, MD, argued that routine screening for brain metastases is unnecessary for patients with either early or metastatic HER2-positive breast cancer.
At Great Debates and Updates in...
05/14/2024
Oncology
Seth Wander, MD, PhD, Massachusetts General Hospital
Videos
Novel Endocrine Agents for Patients With HR-Positive Breast Cancer
05/08/2024

Featuring Seth Wander, MD, PhD

Featuring Seth Wander, MD, PhD ...
At Great Debates and Updates in Women’s Oncology, Seth Wander, MD, PhD, discussed whether novel endocrine agents add anything different from SERDs to treatments for patients with hormone receptor-positive metastatic breast cancer.
At Great Debates and Updates in Women’s Oncology, Seth Wander, MD, PhD, discussed whether novel endocrine agents add anything different from SERDs to treatments for patients with hormone receptor-positive metastatic breast cancer.
At Great Debates and Updates in...
05/08/2024
Oncology
Oladapo Yeku, MD, PhD, FACP
Conference Coverage
Incorporation of Immunotherapy in the Recurrent or Metastatic Setting for Patients With Cervical Cancer
05/08/2024

Featuring Oladapo Yeku, MD, PhD, FACP

Featuring Oladapo Yeku, MD, PhD, FACP...
At the 2024 Great Debates and Updates in Women’s Oncology meeting, Oladapo Yeku, MD, PhD, FACP participated in a debate arguing for the incorporation of immunotherapy for patients with cervical cancer in the recurrent or metastatic setting.
At the 2024 Great Debates and Updates in Women’s Oncology meeting, Oladapo Yeku, MD, PhD, FACP participated in a debate arguing for the incorporation of immunotherapy for patients with cervical cancer in the recurrent or metastatic setting.
At the 2024 Great Debates and...
05/08/2024
Oncology
Ying Liu, MD, MPH
Videos
The Case for Platinum-Based Chemotherapy for Patients With Platinum-Sensitive Recurrent Ovarian Cancer
05/08/2024

Featuring Ying Liu, MD, MPH

Featuring Ying Liu, MD, MPH
At the 2024 Great Debates and Updates in Women’s Oncology meeting, Ying Liu, MD, MPH, makes an argument for platinum-based chemotherapy as the optimal treatment for patients with platinum-sensitive recurrent ovarian cancer.
At the 2024 Great Debates and Updates in Women’s Oncology meeting, Ying Liu, MD, MPH, makes an argument for platinum-based chemotherapy as the optimal treatment for patients with platinum-sensitive recurrent ovarian cancer.
At the 2024 Great Debates and...
05/08/2024
Oncology
Denise Yardley, MD, Sarah Cannon Research Institute
Videos
Is Age 50 Relevant for Decisions in Early HR-Positive Breast Cancer?
05/08/2024

Featuring Denise Yardley, MD

Featuring Denise Yardley, MD
At Great Debates and Updates in Women’s Oncology, Denise Yardley, MD, discusses whether age 50 is relevant for treatment decisions for patients with early HR-positive breast cancer.
At Great Debates and Updates in Women’s Oncology, Denise Yardley, MD, discusses whether age 50 is relevant for treatment decisions for patients with early HR-positive breast cancer.
At Great Debates and Updates in...
05/08/2024
Oncology
Neil Iyengar, MD, Memorial Sloan Kettering Cancer Center
Videos
Sequential Antibody Drug Conjugates for Patients With Metastatic Breast Cancer
05/08/2024

Featuring Neil Iyengar, MD

Featuring Neil Iyengar, MD
At Great Debates and Updates in Women’s Oncology, Neil Iyengar, MD, discusses the lack of data to support the sequential use of antibody drug conjugates for patients with metastatic breast cancer.
At Great Debates and Updates in Women’s Oncology, Neil Iyengar, MD, discusses the lack of data to support the sequential use of antibody drug conjugates for patients with metastatic breast cancer.
At Great Debates and Updates in...
05/08/2024
Oncology
Bradley Monk, MD, FACOG
Conference Coverage
The Case for Early Use of Immunotherapy Plus Radiation/Chemo for Patients With High-Risk Cervical Cancer
05/08/2024

Featuring Bradley Monk, MD, FACOG

Featuring Bradley Monk, MD, FACOG ...
At the 2024 Great Debates and Updates in Women’s Oncology meeting, Bradley Monk, MD, FACOG, argues for the first-line use of immune checkpoint inhibitors plus chemotherapy and radiation therapy for patients with cervical cancer.
At the 2024 Great Debates and Updates in Women’s Oncology meeting, Bradley Monk, MD, FACOG, argues for the first-line use of immune checkpoint inhibitors plus chemotherapy and radiation therapy for patients with cervical cancer.
At the 2024 Great Debates and...
05/08/2024
Oncology
Bradley Monk, MD, FACOG
Conference Coverage
Use of PARP Inhibitors for Maintenance Therapy Among Patients With Advanced Epithelial Ovarian Cancer
05/08/2024

Featuring Bradley Monk, MD, FACOG

Featuring Bradley Monk, MD, FACOG ...
At the 2024 Great Debates and Updates in Women’s Oncology meeting, Bradley Monk, MD, FACOG, discussed PARP inhibitors and determining the optimal maintenance therapy for women with advanced epithelial ovarian cancer. 
At the 2024 Great Debates and Updates in Women’s Oncology meeting, Bradley Monk, MD, FACOG, discussed PARP inhibitors and determining the optimal maintenance therapy for women with advanced epithelial ovarian cancer. 
At the 2024 Great Debates and...
05/08/2024
Oncology
Bradley Monk, MD
Conference Coverage
Front-Line Treatment Options for Ovarian Cancer
12/07/2023
At the Great Debates & Updates in Women’s Oncology meeting, Bradley Monk, MD, discussed molecular testing and advancements in front-line treatment for patients with advanced epithelial ovarian cancer.
At the Great Debates & Updates in Women’s Oncology meeting, Bradley Monk, MD, discussed molecular testing and advancements in front-line treatment for patients with advanced epithelial ovarian cancer.
At the Great Debates & Updates...
12/07/2023
Oncology
Colleen McCormick, MD, MPH
Videos
New and Emerging Targeted Therapies for Relapsing Ovarian Cancer
11/15/2023
At the Great Debates & Updates in Women’s Oncology meeting, Colleen McCormick, MD, MPH, gave an overview of new targeted therapies for patients with relapsing platinum-sensitive and platinum-resistant ovarian cancer.
At the Great Debates & Updates in Women’s Oncology meeting, Colleen McCormick, MD, MPH, gave an overview of new targeted therapies for patients with relapsing platinum-sensitive and platinum-resistant ovarian cancer.
At the Great Debates & Updates...
11/15/2023
Oncology
Oliver Zivanovic, MD, Memorial Sloan Kettering Cancer Center
Videos
In Support of HIPEC as Standard of Care for Stage 3 Ovarian Cancer
11/30/2022
Oliver Zivanovic, MD, defends HIPEC as standard of care treatment for patients with ovarian cancer, a topic he presented at the 2022 Great Debates and Updates in Women’s Oncology virtual meeting.
Oliver Zivanovic, MD, defends HIPEC as standard of care treatment for patients with ovarian cancer, a topic he presented at the 2022 Great Debates and Updates in Women’s Oncology virtual meeting.
Oliver Zivanovic, MD, defends...
11/30/2022
Oncology
Kathleen Moore, MD
Videos
Current and Emerging Therapies for Platinum-Resistant Ovarian Cancer
11/15/2022
Kathleen Moore, MD, gives an overview on recent developments in treatments for advanced stage ovarian cancer, a topic she presented at the 2022 GDU Women’s Oncology virtual meeting.
Kathleen Moore, MD, gives an overview on recent developments in treatments for advanced stage ovarian cancer, a topic she presented at the 2022 GDU Women’s Oncology virtual meeting.
Kathleen Moore, MD, gives an...
11/15/2022
Oncology
Komal Jhaveri, MD
Videos
Novel Antibody Drug Conjugates for Triple-Negative Breast Cancer
11/14/2022
Komal Jhaveri, MD, provides insights and information regarding new and emerging antibody drug conjugate therapies for patients with triple-negative breast cancer, a topic she presented at the 2022 Great Debates & Updates in Women’s Oncology...
Komal Jhaveri, MD, provides insights and information regarding new and emerging antibody drug conjugate therapies for patients with triple-negative breast cancer, a topic she presented at the 2022 Great Debates & Updates in Women’s Oncology...
Komal Jhaveri, MD, provides...
11/14/2022
Oncology
Carrie Langstraat, MD
Videos
HIPEC: Standard of Care for Ovarian Cancer?
11/08/2022
Carrie Langstraat, MD, discusses whether HIPEC should be considered the standard of care for ovarian cancer, a subject she debated at the 2022 Great Debates and Updates in Women’s Oncology virtual meeting.
Carrie Langstraat, MD, discusses whether HIPEC should be considered the standard of care for ovarian cancer, a subject she debated at the 2022 Great Debates and Updates in Women’s Oncology virtual meeting.
Carrie Langstraat, MD, discusses...
11/08/2022
Oncology
Sara Hurvitz, MD
Videos
The Importance of Right Sizing Early HER2 Breast Cancer Treatment
11/07/2022
Sara Hurvitz, MD, discusses the importance of right sizing early HER2 treatment for patients with HER2-positive breast cancer, a topic she presented at the 2022 Great Debates and Updates in Women's Oncology virtual meeting.
Sara Hurvitz, MD, discusses the importance of right sizing early HER2 treatment for patients with HER2-positive breast cancer, a topic she presented at the 2022 Great Debates and Updates in Women's Oncology virtual meeting.
Sara Hurvitz, MD, discusses the...
11/07/2022
Oncology
Kevin Kalinsky, MD, MS, Director, Glenn Family Breast Center, Winship Cancer Institute at Emory University
Videos
Right Sizing HR-Positive Breast Cancer Adjuvant Therapy With Genomic Risk Stratifying Assays
10/28/2022
Kevin Kalinsky, MD, MS, shares his insights on right sizing adjuvant therapy for HR-positive breast cancer with the use of genomic risk stratifying assays.
Kevin Kalinsky, MD, MS, shares his insights on right sizing adjuvant therapy for HR-positive breast cancer with the use of genomic risk stratifying assays.
Kevin Kalinsky, MD, MS, shares...
10/28/2022
Oncology
BJ Rimel, MD
Videos
Treatment for Advanced and Recurrent Endometrial Cancer
10/20/2022
BJ Rimel, MD, shares important considerations for clinicians when caring for patients with advanced and recurrent endometrial cancer, a topic she presented at the 2022 GDU Women’s Oncology virtual meeting.
BJ Rimel, MD, shares important considerations for clinicians when caring for patients with advanced and recurrent endometrial cancer, a topic she presented at the 2022 GDU Women’s Oncology virtual meeting.
BJ Rimel, MD, shares important...
10/20/2022
Oncology
Ritu Salani, MD
Videos
Emerging Opportunities for the Treatment of Cervical Cancer
10/20/2022
Ritu Salani, MD, reviews new and upcoming opportunities for the treatment of patients with cervical cancer, a topic she presented at the 2022 GDU Women’s Oncology virtual meeting.
Ritu Salani, MD, reviews new and upcoming opportunities for the treatment of patients with cervical cancer, a topic she presented at the 2022 GDU Women’s Oncology virtual meeting.
Ritu Salani, MD, reviews new and...
10/20/2022
Oncology
BJ Rimel, MD
Videos
Current and Future Treatment Paradigms in Second-Line Endometrial Cancer
10/19/2022
BJ Rimel, MD, shares new and upcoming treatments in the second-line setting for patients with endometrial cancer, a topic she presented at the 2022 GDU Women’s Oncology virtual meeting.
BJ Rimel, MD, shares new and upcoming treatments in the second-line setting for patients with endometrial cancer, a topic she presented at the 2022 GDU Women’s Oncology virtual meeting.
BJ Rimel, MD, shares new and...
10/19/2022
Oncology
Matteo Lambertini, MD, PhD
Videos
Considerations When Treating Premenopausal Patients With Breast Cancer
10/19/2022
Matteo Lambertini, MD, PhD, discusses insights, strategies, and potential complications when treating a younger patient with breast cancer, a topic he presented at the 2022 GDU Women’s Oncology virtual meeting.
Matteo Lambertini, MD, PhD, discusses insights, strategies, and potential complications when treating a younger patient with breast cancer, a topic he presented at the 2022 GDU Women’s Oncology virtual meeting.
Matteo Lambertini, MD, PhD,...
10/19/2022
Oncology
BJ Rimel, MD
Videos
Caring for Transgender and Special Population Patients as an Oncologist
10/17/2022
BJ Rimel, MD, shares important tips and insights regarding the care for transgender and special population patients being treated for cancer, a topic she presented at the 2022 GDU Women’s Oncology virtual meeting.
BJ Rimel, MD, shares important tips and insights regarding the care for transgender and special population patients being treated for cancer, a topic she presented at the 2022 GDU Women’s Oncology virtual meeting.
BJ Rimel, MD, shares important...
10/17/2022
Oncology
Anne Katz, PhD, RN
Videos
Discussing Sexual Side Effects Caused by Cancer Care
10/17/2022
Anne Katz, PhD, RN, shares her insights on talking to patients about the sexual side effects they experience during and after undergoing cancer treatments.
Anne Katz, PhD, RN, shares her insights on talking to patients about the sexual side effects they experience during and after undergoing cancer treatments.
Anne Katz, PhD, RN, shares her...
10/17/2022
Oncology
Javier Cortés
Interview
Dr Cortés Discusses First Line Immunotherapy in mTNBC
05/11/2021
Javier Cortés, MD, PhD, International Breast Cancer Center, discusses the role of immunotherapy in the first line treatment of metastatic triple-negative breast cancer, presented at the 2021 Great Debates and Updates in Women's Oncology...
Javier Cortés, MD, PhD, International Breast Cancer Center, discusses the role of immunotherapy in the first line treatment of metastatic triple-negative breast cancer, presented at the 2021 Great Debates and Updates in Women's Oncology...
Javier Cortés, MD, PhD,...
05/11/2021
Oncology
Margaret Gatti-Mays, MD, MPH, FACP
Videos
Dr Gatti-Mays Highlights Treatment Algorithms in mHER2+ Breast Cancer
05/11/2021
Margaret Gatti-Mays, MD, MPH, FACP, discusses treatment algorithms for metastatic HER2+ breast cancer, a topic discussed at the 2021 Great Debates & Updates in Women's Oncology Meeting. 
Margaret Gatti-Mays, MD, MPH, FACP, discusses treatment algorithms for metastatic HER2+ breast cancer, a topic discussed at the 2021 Great Debates & Updates in Women's Oncology Meeting. 
Margaret Gatti-Mays, MD, MPH,...
05/11/2021
Oncology
Conference Insider
Current and Emerging Therapies in Platinum Resistant Ovarian Malignancies
04/24/2021
At the virtual 2021 Great Debates & Updates in Women’s Oncology meeting, Shannon N. Westin, MD, MPH, provided an overview on the current and emerging therapies for platinum-resistant ovarian malignancies.
At the virtual 2021 Great Debates & Updates in Women’s Oncology meeting, Shannon N. Westin, MD, MPH, provided an overview on the current and emerging therapies for platinum-resistant ovarian malignancies.
At the virtual 2021 Great...
04/24/2021
Oncology
Dr Hayes Discusses Extended Endocrine Therapy in ER+ Early Stage Breast Cancer
Videos
Dr Hayes Discusses Extended Endocrine Therapy in ER+ Early Stage Breast Cancer
04/23/2021
Daniel Hayes, MD, discusses his recent debate with Nikhil Wagle, MD, regarding the benefits of extended endocrine therapy.
Daniel Hayes, MD, discusses his recent debate with Nikhil Wagle, MD, regarding the benefits of extended endocrine therapy.
Daniel Hayes, MD, discusses his...
04/23/2021
Oncology
News
Personalized Treatments for HER2+ Breast Cancer
04/23/2021
At the Great Debates & Updates in Women’s Oncology meeting, Shanu Modi, MD, provided insight on personalized treatments for HER2+ breast cancer.
At the Great Debates & Updates in Women’s Oncology meeting, Shanu Modi, MD, provided insight on personalized treatments for HER2+ breast cancer.
At the Great Debates & Updates...
04/23/2021
Oncology
News
Experts Debate Readiness of Immunotherapy for Early TNBC
04/23/2021
At the Great Debates & Updates in Women's Oncology meeting, Heather McArthur, MD, MPH, participated in a lively debate about the comprehensive use of immunotherapy for TNBC.
At the Great Debates & Updates in Women's Oncology meeting, Heather McArthur, MD, MPH, participated in a lively debate about the comprehensive use of immunotherapy for TNBC.
At the Great Debates & Updates...
04/23/2021
Oncology
Women's Oncology Conference Welcomes in a New Chapter for Great Debates and Updates
Videos
Women's Oncology Conference Welcomes in a New Chapter for Great Debates and Updates
02/01/2021
From the organizers of Great Debates & Updates, we're excited to announce a new interactive CME series connecting those treating breast and gynecologic cancers.
From the organizers of Great Debates & Updates, we're excited to announce a new interactive CME series connecting those treating breast and gynecologic cancers.
From the organizers of Great...
02/01/2021
Oncology

Advertisement

Advertisement

Advertisement

About

From the organizers of Great Debates & Updates, we're excited to announce a new interactive CME series connecting those treating breast and gynecologic cancers—for 2 days of interactive, expertly crafted oncology education.

Great Debates & Updates in Women's Oncology will focus on how new information fits into current community practice. Attendees will get an insightful look at more than one side of a question, giving them a chance to really engage in the discussions. These 2 conferences are sure to be an engaging, interactive educational opportunity for attendees, with several opportunities to network with both faculty and attendees.

 

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement